Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Harding Loevner International Equity. This analysis is provided for institutional research purposes only and is not investment advice.
"International Equity underperformed due to health care policy headwinds despite strong sector fundamentals. AI-driven semiconductor demand boosted tech holdings while new aerospace positions in Safran and Ryanair capitalize on commercial aviation recovery."
Harding Loevner's International Equity strategy returned 9.23% net in Q2 2025, trailing the MSCI ACWI ex US Index's 12.3% gain. The underperformance was primarily driven by the fund's overweight position in Health Care, which faced significant political and regulatory headwinds despite strong fundamentals. Policy uncertainty around drug pricing reforms, Medicaid cuts, and reduced NIH funding weighed on the sector. However, the fund believes these challenges are transitory and maintains its overweight position. The portfolio benefited from AI-related demand, with semiconductor equipment suppliers ASML and Disco Corp delivering strong returns alongside TSMC. The fund established new positions in aerospace companies Safran and Ryanair to capitalize on commercial aviation recovery, with global air traffic expected to grow 3.6-4.2% annually through 2044. European defense spending commitments provide additional upside for aerospace-focused companies. The fund continues to focus on companies with resilient cash flows, innovation pipelines, and geographic diversification to mitigate policy risks.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
The fund demonstrates high conviction through maintaining overweight health care positions despite underperformance and establishing new concentrated positions in aerospace. Named holdings with specific thesis explanations and willingness to hold through volatility indicate strong conviction.
Growth Outlook
The manager expresses cautious optimism about long-term fundamentals while acknowledging near-term headwinds. Positive on commercial aerospace recovery and AI demand, but concerned about health care policy uncertainty and trade tensions.
Risk Appetite
The fund maintains overweight positions in challenged sectors like health care and established new positions in aerospace, showing selective risk-taking. However, the focus on quality companies and defensive characteristics suggests moderate risk appetite.
Capital Deployment
The fund established four new positions (NetEase, Novartis, Ryanair, Safran, SF Holding) while selling two (ENN Energy, Shimano), indicating moderate net deployment activity. Cash position of 3.6% suggests measured deployment.
Forward Guidance
The manager is selectively deploying capital with new positions in Safran and Ryanair while maintaining conviction positions in health care. The tone suggests measured optimism about future opportunities.
Language Signal
Language is balanced with both opportunity and risk discussions. Positive terms around aerospace recovery and AI demand are offset by extensive discussion of health care headwinds and policy uncertainty.
Perceived Risk
The manager identifies multiple specific risks including health care policy uncertainty, trade tensions affecting industrial companies, and challenges to European defense spending commitments. Risks are discussed in detail with potential impacts outlined.
Opportunity Density
The manager sees selective opportunities in aerospace and continued AI demand while acknowledging challenges in health care. The establishment of new positions suggests adequate opportunity set, though selectivity is emphasized.
Time Horizon
The fund demonstrates long-term orientation by maintaining positions through near-term volatility and focusing on secular trends like aerospace recovery through 2044. The willingness to hold health care through policy uncertainty indicates multi-year investment horizons.
